Related references
Note: Only part of the references are listed.3D QSAR for GSK-3β inhibition by indirubin analogues
N Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2006)
Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine
G Eisenbrand et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
The Wnt signaling pathway in development and disease
CY Logan et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China
ZJ Xiao et al.
LEUKEMIA & LYMPHOMA (2002)
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
A Martinez et al.
MEDICINAL RESEARCH REVIEWS (2002)
Share Paper
